Physicochemical properties of oxamniquine indicate a new polymorphic form

Area of Science:

• Pharmaceutical Sciences
• Medicinal Chemistry
• Solid-State Chemistry

Background:

• Oxamniquine is a critical anti-schistosomal agent.
• Understanding its physicochemical properties is vital for optimizing therapeutic outcomes.
• Previous data on oxamniquine's solid-state characteristics and dissolution behavior is limited.

Purpose of the Study:

• To characterize the dissolution rate, chemical stability, and thermal properties of oxamniquine.
• To identify and characterize any novel polymorphic forms of oxamniquine.
• To assess the physical stability of newly identified polymorphs in relation to known forms.

Main Methods:

• Dissolution rate testing under controlled conditions.
• Chemical stability studies in aqueous solutions at physiological temperature.
• Thermal analysis techniques (e.g., Differential Scanning Calorimetry, Thermogravimetric Analysis) to investigate thermal behavior and polymorphism.
• X-ray diffraction or other methods to confirm polymorphic forms.

Main Results:

• Oxamniquine demonstrated a slow dissolution rate, with 40-70% dissolving within 1 hour.
• The drug exhibited good chemical stability in water for at least 21 days at 37°C.
• Evidence for a previously unreported polymorph, designated Form III, was identified through dissolution and thermal analysis.
• Form III appears to possess intermediate physical stability compared to known Forms I and II.

Conclusions:

• The slow dissolution rate of oxamniquine may contribute to its variable clinical efficacy.
• A new polymorph, Form III, has been discovered, offering insights into oxamniquine's solid-state landscape.
• The intermediate stability of Form III warrants further investigation for its potential impact on drug formulation and performance.